SG11201906781VA - Antimicrobial compositions comprising copper-hydroxypyrone complexes - Google Patents

Antimicrobial compositions comprising copper-hydroxypyrone complexes

Info

Publication number
SG11201906781VA
SG11201906781VA SG11201906781VA SG11201906781VA SG11201906781VA SG 11201906781V A SG11201906781V A SG 11201906781VA SG 11201906781V A SG11201906781V A SG 11201906781VA SG 11201906781V A SG11201906781V A SG 11201906781VA SG 11201906781V A SG11201906781V A SG 11201906781VA
Authority
SG
Singapore
Prior art keywords
copper
international
complexes
pct
peg
Prior art date
Application number
SG11201906781VA
Inventor
Jonathan Joseph Powell
Nuno Faria
Carlos Andre Passos Bastos
Original Assignee
Res & Innovation Uk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res & Innovation Uk filed Critical Res & Innovation Uk
Publication of SG11201906781VA publication Critical patent/SG11201906781VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Abstract

International Patent Classification: A61K 31/351 (2006.01) A61P 31/04 A61K 33/34 (2006.01) A61P 31/06 A61K 9/00 (2006.01) A61P 31/10 (2006.01) (2006.01) (2006.01) (21) International Application Number: (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 09 August 2018 (09.08.2018) WIP0 I PCT ill 1111u°11101llioIIl °nolo DID maim Eno iflo oimIE (10) International Publication Number WO 2018/141989 Al TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). (22) International Filing Date: Declarations under Rule 4.17: — of inventorship (Rule 4.17(iv)) PCT/EP2018/052958 Published: — with international search report (Art. 21(3)) 06 February 2018 (06.02.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 1701944.9 06 February 2017 (06.02.2017) GB (71) Applicant: UNITED KINGDOM RESEARCH AND IN- NOVATION [GB/GB]; Polaris House, North Star Avenue, Swindon SN2 1FL (GB). (72) Inventors: POWELL, Jonathan Joseph; 145 Histon Road, Cambridge Cambridgeshire CB4 3JD (GB). FARIA, Nuno, Jorge, Rodrigues; 3 Starey Close, Milton Ernest Bedfordshire MK44 1RX (GB). BASTOS, Carlos Andre Passos; 50 Tiverton Way, Cambridge Cambridgeshire CB1 3TU (GB). = (74) Agent: KIDDLE, Simon et al.; Mewburn Ellis LLP, City Tower, 40 Basinghall Street, London Greater London EC2V 5DE (GB). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, 1-1 00 CN (54) Title: ANTIMICROBIAL COMPOSITIONS COMPRISING COPPER-HYDROXYPYRONE COMPLEXES 1-1 I I - (57) : Copper based antibacterial agents are described based on amphiphilic copper complexes formed between copper and 1-1 hydroxypyrones, such as maltol. In further aspects, the present invention relates to PEG based-ointments showing that they are partic- ularly effective for topical delivery of amphiphilic complexes of copper. In particular, PEG ointments were shown to limit bacterial 1-1 © growth, even when in the absence of copper agent. However, this bacteriostatic effect is shown herein to become a true biocidal effect N when copper hydroxypyrones are added to the PEG.
SG11201906781VA 2017-02-06 2018-02-06 Antimicrobial compositions comprising copper-hydroxypyrone complexes SG11201906781VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1701944.9A GB201701944D0 (en) 2017-02-06 2017-02-06 Antimicrobial compositions and their uses
PCT/EP2018/052958 WO2018141989A1 (en) 2017-02-06 2018-02-06 Antimicrobial compositions comprising copper-hydroxypyrone complexes

Publications (1)

Publication Number Publication Date
SG11201906781VA true SG11201906781VA (en) 2019-08-27

Family

ID=58462497

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201906781VA SG11201906781VA (en) 2017-02-06 2018-02-06 Antimicrobial compositions comprising copper-hydroxypyrone complexes

Country Status (10)

Country Link
US (1) US11000502B2 (en)
EP (1) EP3576730A1 (en)
JP (1) JP2020506201A (en)
CN (1) CN110248654A (en)
AU (1) AU2018216241A1 (en)
BR (1) BR112019016189A2 (en)
CA (1) CA3051519A1 (en)
GB (1) GB201701944D0 (en)
SG (1) SG11201906781VA (en)
WO (1) WO2018141989A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111647533A (en) * 2020-06-16 2020-09-11 科里思特(福建)生物科技有限公司 Bacillus subtilis, preparation and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07138155A (en) * 1993-11-12 1995-05-30 Otsuka Pharmaceut Co Ltd Antimicrobial agent
GB9621273D0 (en) * 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
DE69922817T2 (en) * 1998-09-23 2005-06-16 Unilever N.V. ORAL COMPOSITION WITH IMPROVED BLEACHING EFFECT
US6505233B1 (en) 1999-08-30 2003-01-07 Zaplet, Inc. Method for communicating information among a group of participants
JP2002255956A (en) 2001-02-27 2002-09-11 Sumitomo Chem Co Ltd Antifungal agent
JP2009256228A (en) * 2008-04-15 2009-11-05 Lion Corp Liquid composition for oral cavity
GB201402672D0 (en) * 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions

Also Published As

Publication number Publication date
EP3576730A1 (en) 2019-12-11
AU2018216241A1 (en) 2019-08-29
US11000502B2 (en) 2021-05-11
CA3051519A1 (en) 2018-08-09
US20190380996A1 (en) 2019-12-19
BR112019016189A2 (en) 2020-04-14
WO2018141989A1 (en) 2018-08-09
JP2020506201A (en) 2020-02-27
GB201701944D0 (en) 2017-03-22
CN110248654A (en) 2019-09-17

Similar Documents

Publication Publication Date Title
SG11201806624XA (en) Deposition of molybdenum thin films using a molybdenum carbonyl precursor
SG11201805070TA (en) Vapor disposition of silicon-containing films using penta-substituted disilanes
SG11201907650RA (en) Personal therapy and exercise monitoring and oversight devices, systems, and related methods
SG11201906534XA (en) Antifouling composition
SG11201908171TA (en) Compounds and compositions for treating hematological disorders
SG11201803703UA (en) Anti-complement factor c1q fab fragments and uses thereof
SG11201810466PA (en) Compositions and methods related to engineered fc constructs
SG11201806485RA (en) Pyrrolobenzodiazepine conjugates
SG11201809976PA (en) Protection of plant extracts and compounds from degradation
SG11201908114UA (en) Pyrimidopyrimidinones useful as wee-1 kinase inhibitors
SG11201805001UA (en) Method of treating influenza a
SG11201809395XA (en) Executable logic for processing keyed data in networks
SG11201407812SA (en) Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201809830WA (en) Selective reduction of cysteine-engineered antibodies
SG11201407536UA (en) Topical pharmaceutical compositions comprising terbinafine and urea
SG11201407801VA (en) Methods for use of mixed multifunctional surfaces for reducing aggregate content in protein preparations
SG11201810192TA (en) Antibacterial compositions
SG11201811788SA (en) Antibodies with low immunogenicity and uses thereof
SG11201901188VA (en) Metal powder feedstocks for additive manufacturing, and system and methods for producing the same
SG11201811341QA (en) Sugar composition
SG11201900123TA (en) Compositions and methods for treating frontotemporal dementia
SG11201907950VA (en) Complexes for treating sensitivity
SG11201909906QA (en) Organic compounds
SG11201408223UA (en) Tear tape for product wrapper